Sunday 18 October 2026
Export DHAI’s income statement to Excel — free account
DIH Holding US, Inc.
DHAI Healthcare Medical Devices
DIH Holding US, Inc.’s revenue for fiscal 2025 (year ended March 2025) was $62.9 million, down 2.50% from fiscal 2024. In the quarter to March 2025, revenue fell 30.7%, EPS grew 30.0% and free cash flow fell 167.9%, each against the same quarter a year earlier.
0.00
0.00
NaN
Follow DHAI
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to March
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price, $ | |||||||||||||||
| Price, $ | Low | — | — | — | — | — | — | 238.50 | 103.50 | 17.95 | 0.00 |
Analyst estimates 2026–2028 Powerpack |
|||
| High | — | — | — | — | — | — | 255.75 | 347.50 | 147.00 | 73.25 | |||||
| People | |||||||||||||||
| People | Employees | — | — | — | — | — | — | 3 | 242 | 192 | 178 | ||||
| Revenue/emp, $m | — | — | — | — | — | — | 0.00 | 0.00 | 0.34 | 0.35 | |||||
| Income, $m | |||||||||||||||
| Income, $m | Revenue | — | — | — | — | — | — | — | 54 | 64 | 63 | ||||
| Gross margin, % | — | — | — | — | — | — | — | 56.58 | 46.18 | 51.24 | |||||
| EBT | — | — | — | — | — | 0 | 7 | 1 | (7) | (8) | |||||
| EBT margin, % | — | — | — | — | — | 0.00 | 0.00 | 0.00 | (11.16) | (13.15) | |||||
| Net income | — | 0 | — | — | — | 0 | 7 | 1 | (8) | (9) | |||||
| Depreciation | — | — | — | — | — | — | 0 | 0 | 0 | 1 | |||||
| Per share, $ | |||||||||||||||
| Per share, $ | Revenue | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 1,527.80 | 1,099.02 | ||||
| Earnings | — | — | — | — | — | (0.05) | 31.06 | 2.99 | (200.07) | (151.68) | |||||
| Cash flow | — | — | — | — | — | 0.00 | (5.16) | (3.24) | 123.03 | (72.45) | |||||
| Capex | — | — | — | — | — | 0.00 | 0.00 | 0.00 | (4.79) | (9.37) | |||||
| Free cash flow | — | — | — | — | — | 0.00 | (5.16) | (3.24) | 118.25 | (81.82) | |||||
| Book value | — | — | — | — | — | 0.08 | (35.85) | (55.79) | (771.23) | (649.21) | |||||
| Shares, m | — | — | — | — | — | 0 | 0 | 0 | 0 | 0 | |||||
| Valuation, × | |||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | — | — | 23.52 | 0.00 | 0.00 | ||||
| P/S | — | — | — | — | — | — | — | 0.00 | 0.00 | 0.01 | |||||
| P/B | — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | |||||
| EV/Sales | — | — | — | — | — | — | — | 0.00 | 0.00 | 0.15 | |||||
| EV/FCF | — | — | — | — | — | — | — | (45.22) | 1.77 | (2.02) | |||||
| Cash, $m | |||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | — | — | 0 | (1) | (1) | 5 | (4) | ||||
| Capex | — | — | — | — | — | — | 0 | 0 | 0 | (1) | |||||
| Free cash flow | — | — | — | — | — | 0 | (1) | (1) | 5 | (5) | |||||
| Balance, $m | |||||||||||||||
| Balance, $m | Working capital | — | — | — | — | — | 0 | 0 | (5) | (18) | (22) | ||||
| Total debt | — | — | — | — | — | 0 | 0 | 2 | 11 | 11 | |||||
| Net debt | — | — | — | — | — | 0 | 0 | 2 | 8 | 9 | |||||
| Shareholders’ equity | — | — | — | — | — | 0 | (8) | (12) | (33) | (37) | |||||
| Returns, % | |||||||||||||||
| Returns, % | ROA | — | — | — | — | — | (5.36) | 6.35 | 1.42 | (17.89) | (27.77) | ||||
| ROIC | — | — | — | — | — | (3.25) | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| ROE | — | — | — | — | — | 0.00 | (173.87) | (3.13) | 37.95 | 24.90 | |||||
Negative figures in brackets.
Fiscal years to Mar 2025 · latest quarter Mar 2025 · fundamentals updated 28 Sep 2026
Charts ten years each
DIH Holding US, Inc. vs peers in Medical Devices (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| BIOLQ Biolase, Inc. | $2.3M | — (loss-making) | — (loss-making) | −0.65% (below 0%: shrinking) | n/m | −60.22% (below 0%: shrinking) | 40.39% | (6.41%) | Compare |
| XAIR Beyond Air, Inc. | $2.2M | — (loss-making) | — (loss-making) | +0.45% (above 0%: growing) | n/m | −9.10% (below 0%: shrinking) | 12.73% | (373.98%) | Compare |
| NUVOQ Holdco Nuvo Group D.G Ltd. | $2.1M | — (loss-making) | — | — | n/m | −1.05% (below 0%: shrinking) | 0.00% | 0.00% | Compare |
| VJET Flyte Aviation, Inc. | $2.1M | — (loss-making) | — (loss-making) | +380.66% (above 0%: growing) | n/m | −26.70% (below 0%: shrinking) | 9.62% | (388.13%) | Compare |
| NUWE Nuwellis, Inc. | $2.0M | — (loss-making) | — (loss-making) | +14.14% (above 0%: growing) | n/m | −51.55% (below 0%: shrinking) | 76.08% | (160.94%) | Compare |
| AFIB Acutus Medical, Inc. | $1.7M | — (loss-making) | — (loss-making) | +204.18% (above 0%: growing) | n/m | +76.40% (above 0%: growing) | 14.20% | (3.81%) | Compare |
| DHAI DIH Holding US, Inc. | $1.6M | — (loss-making) | — | −30.67% (below 0%: shrinking) | n/m | −167.90% (below 0%: shrinking) | 50.33% | (33.62%) | |
| DYNTQ Dynatronics Corporation | $1.2M | — (loss-making) | — (loss-making) | −7.61% (below 0%: shrinking) | n/m | −193.04% (below 0%: shrinking) | 24.65% | (1.26%) | Compare |
| THMO ThermoGenesis Holdings, Inc. | $1.1M | — (loss-making) | 5.5× | +6.42% (above 0%: growing) | n/m | +62.12% (above 0%: growing) | 43.92% | (20.35%) | Compare |
| Median of peers | $2.0M | — | — | +6.42% | — | −17.90% | 19.42% | (13.38%) |
DIH Holding US, Inc. (DHAI) key facts
- Concern: DIH Holding US, Inc.’s revenue for fiscal 2025 (year ended March 2025) was $62.9 million, down 2.50% from fiscal 2024.
- DIH Holding US, Inc. (DHAI) is a Medical Devices company in the Healthcare sector.
- Return on equity was 24.9% and debt-to-equity -0.30.
- Its Piotroski F-score is 4 out of 9 and its Altman Z-score is −1.78 (distress zone) for fiscal 2025.
DIH Holding US, Inc. (DHAI) Latest News
No news at this impact. Lower the threshold for more.